Bristol Myers Squibb’s Cobenfy is the first treatment in seven decades that does not modulate dopaminergic or serotonergic transmission.
Oppenheimer boosted Netflix's price target, pointing to the benefits of the biggest streaming service's live events.
Here’s what could be next for the AI network provider.
Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc (NYSE:GRND) with a Buy rating and a price target of $20. Grindr is an online dating
The stainless steel market experienced a challenging year in 2024, characterized by weak demand, oversupply, and falling nickel prices.
PLBY Group, Inc. (NASDAQ:PLBY) shares rose following the announcement of an expanded partnership with Byborg Enterprises, which includes a commitment
DKNG just pulled back to its historically bullish 80-day moving average
The Nasdaq climbed to a fresh high Monday as tech stocks gained ahead of an expected decision on interest rates from the Federal Reserve later this week.
Last week's bond-market wobble hasn't damped bets on a year-end stocks rally, with more gains expected in 2025.
On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23.
